-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Keros Therapeutics, Inc. quarterly and annual Revenues in USD history and change rate from 31 Mar 2024 to 31 Dec 2025.
- Keros Therapeutics, Inc. Revenues for the quarter ending 31 Dec 2025 was $380,000.
- Keros Therapeutics, Inc. Revenues for the twelve months ending 31 Dec 2025 was $243,864,000.
- Keros Therapeutics, Inc. annual Revenues for 2025 was $243,864,000.